Think Tank Drugs Program
Andrew Dahlem, PhD, chief of clinical pharmacology and senior research professor of medicine at IU School of Medicine and Richard Taylor, PhD, professor of chemistry and biochemistry at the University of Notre Dame and director of the Molecular Therapeutics Program for the Indiana CTSI, co-lead the Think Tank pharmaceutical program.
Drug Think Tank
Chair: Andy Dahlem, IU School of Medicine
Co-Chair: Rich Taylor, University of Notre Dame
Regulatory Rep: Chris Caldwell, IU School of Medicine
Standing Members:
- Alan Palkowitz, IU School of Medicine
- Timothy Richardson, IU School of Medicine
- Adrienne Takacs, IU School of Medicine/Eli Lilly
- Zhong Yin-Zhang, Purdue University
- Yvonne Lai, Indiana University
- Mark Kelley, IU School of Medicine
- Brian Blagg, University of Notre Dame
- Ramaswamy Subramanian, Purdue University
- Jay McGill, Indiana Biosciences Research Institute
- Kim Saxton, IU Kelley School of Business
Navigator: Padma Portonovo, IU School of Medicine
Related Indiana CTSI Programs:
- Indiana Center for Biomedical Innovation (ICBI)
- Concepts to Clinic Project Development Team
- TL1 Postdoctoral Fellowship, Innovation-Entrepreneurship Track
- For applications specific to Alzheimer’s Disease and Cancer:
TREAT-AD Center for Alzheimer’s Disease Drug Discovery
IU Simon Comprehensive Cancer Center (IUSCCC) Cancer Drug Discovery & Development (CDDD) Working Group Platform
